MetLife stock (US59156R1086): JP Morgan raises price target to $96

JP Morgan maintained its Overweight rating on MetLife while raising the price target to $96 from $95 on May 12, 2026, reflecting a 1.05% upside adjustment based on recent management discussions, according to GuruFocus as of May 12, 2026. This follows TD Cowen's recent hike to $91 from $90 about five days prior. MetLife's shares traded at approximately $77.93 in extended trading on May 12, 2026, on the NYSE.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

MetLife: core business model

MetLife provides insurance and employee benefit programs to individuals and businesses worldwide, with a strong emphasis on the US market where it holds significant presence in group benefits and retirement services. The company operates through segments including US, Asia, Latin America, Europe, Middle East and Africa (EMEA), and the MetLife Holdings. Core offerings encompass life insurance, annuities, and dental/vision plans, serving millions of customers.

MetLife's model relies on a diversified portfolio to mitigate risks, with the US segment generating the largest share of adjusted earnings. In recent quarters, strength in Asia has bolstered performance, as noted in Q3 2025 results where lower costs and regional growth drove beats, per Zacks as of 2026.

Main revenue and product drivers for MetLife

Group Benefits is a primary revenue driver in the US, offering disability, dental, and accident insurance to employers. Retirement and Income Solutions contribute through annuities and stable value products, appealing to US investors amid retirement planning trends. Asia's expanding middle class fuels premium growth in life insurance.

MetLife declared preferred stock dividends in August 2025, including fixed and floating rate series payable in September 2025, underscoring its commitment to shareholder returns with a common stock dividend yield around 2.72% as of recent data from Robinhood as of 2026.

Industry trends and competitive position

The US insurance sector faces interest rate volatility and regulatory scrutiny, yet benefits from rising demand for employee benefits post-pandemic. MetLife competes with Prudential, Principal Financial, and others, maintaining a market cap over $54 billion. Its global footprint differentiates it, with Asia growth offsetting mature US markets.

Why MetLife matters for US investors

As a NYSE-listed blue-chip insurer, MetLife offers US investors exposure to stable cash flows from premiums and investments, plus dividends attractive for income strategies. Its role in the US group benefits market ties performance to economic health and employment trends.

Conclusion

Recent analyst adjustments from JP Morgan and TD Cowen highlight MetLife's resilient operations amid global insurance dynamics. Dividend declarations and segment strength provide tailwinds, while US market leadership ensures relevance. Investors track upcoming earnings and economic indicators for further direction.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.